Cargando…
An Exon Signature to Estimate the Tumor Mutational Burden of Right-sided Colon Cancer Patients
The clinical applicability of the whole-exome sequencing (WES) in estimating tumor mutational burden (TMB) is currently limited by high cost, time-consuming and tissue availability. And given to the differences in the mutational landscapes among different types of cancer, we aimed to develop a cance...
Autores principales: | Guo, Wenbing, Fu, Yelin, Jin, Liangliang, Song, Kai, Yu, Ruihan, Li, Tianhao, Qi, Lishuang, Gu, Yunyan, Zhao, Wenyuan, Guo, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959028/ https://www.ncbi.nlm.nih.gov/pubmed/31949492 http://dx.doi.org/10.7150/jca.34363 |
Ejemplares similares
-
A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon Cancer
por: Fu, Yelin, et al.
Publicado: (2019) -
A Qualitative Transcriptional Signature for Predicting CpG Island Methylator Phenotype Status of the Right-Sided Colon Cancer
por: You, Tianyi, et al.
Publicado: (2020) -
Individualized predictive signatures for 5‐fluorouracil‐based chemotherapy in right‐ and left‐sided colon cancer
por: Song, Kai, et al.
Publicado: (2018) -
An individualized gene expression signature for prediction of lung adenocarcinoma metastases
por: Qi, Lishuang, et al.
Publicado: (2017) -
An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
por: Qi, Lishuang, et al.
Publicado: (2016)